Cytek Biosciences (CTKB) Inventory (2020 - 2026)

Cytek Biosciences has reported Inventory for 7 years, with the latest figure at $49.8 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 9.8% year-over-year to $49.8 million; the trailing twelve-month figure through Mar 2026 stood at $49.8 million (up 9.8% YoY), and the FY2025 full-year result was $48.4 million, up 10.33% from the prior year.
• Inventory for Q1 2026 stood at $49.8 million, up from $48.4 million in the prior quarter.
• The five-year high for Inventory was $69.5 million in Q1 2023, with the low at $38.0 million in Q1 2022.
• Historically, Inventory has averaged $52.0 million across 5 years, with a median of $49.5 million in 2025.
• Annual changes were most pronounced in 2023 — Inventory jumped 82.99% — and 2024, when it tumbled 30.02%.
• Cytek Biosciences' Inventory stood at $48.2 million in 2022, then gained by 26.42% to $60.9 million in 2023, then declined by 27.9% to $43.9 million in 2024, then climbed by 10.33% to $48.4 million in 2025, then climbed by 2.81% to $49.8 million in 2026.
• The last three Inventory figures came in at $49.8 million (Q1 2026), $48.4 million (Q4 2025), and $51.6 million (Q3 2025), per Business Quant data.